MMacquarie XXPeng · XPEV
Macquarie Lowers XPeng (9868:HK) Price Target to HK$70
Rating
Buy
Price target
HK$70
Previous
—
Implied upside
+474%
Macquarie analyst Eugene Hsiao lowered the price target on XPeng (H-Shares) (9868:HK) (NYSE: XPEV) to HK$70 (from HK$73) while maintaining a Outperform rating.
“• 2Q volume and revenue were in line and gross margin beat, but adjusted net profit missed Bloomberg consensus. • 3Q volume guidance was soft, though management said 4Q could accelerate, with monthly sales of about 60k units. • Maintain Outperform.
We cut H-share and US ADR target prices 4% and 5% on lower peer valuations, while volume momentum is rebuilding.”
Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
